Amneal Pharmaceuticals, Inc. AMRX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow yield?
- Amneal Pharmaceuticals, Inc. (AMRX) reported free cash flow yield of 6.1% in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s free cash flow yield changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s free cash flow yield decreased by 36.5% year-over-year, from 9.6% to 6.1%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s free cash flow yield?
- Over 3 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s free cash flow yield has grown at a -47.6% compound annual growth rate (CAGR), from 47.3% to 6.8%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.